Nr Conclusion Quality level (1) Serious PS related adverse events occur more frequently (I) In children with an underlying disease. Level 1 (A1) Green et al. 2009 [30 ] (B) Sanborn et al. 2005 [27 ], Cravero et al. 2009 [26 ] (C) Malviya et al. 1997 [28 ], Vespasiano et al. 2007 [29 ] (II) If multiple sedatives are used Level 1 (A1) Green et al. 2009 [30 ] (B) Hoffman et al. 2002 [13 ], Pitetti et al. 2003 [32 ], Sanborn et al. 2005 [27 ], Cravero et al. 2009 [26 ] (C) Gall et al. 2001 [31 ] (III) In young children Level 1 (A1) Green et al. 2009 (
2 years) [30 ] (B) Cravero et al. 2009 (
6 months) [26 ] (C) Malviya et al. 1997 (
1 year) [28 ], Gall et al. 2001 (
1 year) [31 ] (IV) In certain drugs compared to others : (IV.1) The combination of a benzodiazepine with an opiate (e.g., midazolam + fentanyl) is associated with a Level 2 higher risk of respiratory complications (21–23%) compared to the use of midazolam alone or ketamine with midazolam. (A2) Yildizdas et al. 2004 [8 ] (B) Pitetti et al. 2003 [32 ], Roback et al. 2005 [33 ], Newman et al. 2003 [34 ] (IV.2) Oral pentobarbital is associated with less adverse events compared to oral chloral hydrate Level 3 (B) Mason et al. 2004 [35 ] (IV.3) In comparison with ketamine, midazolam and ketamine + midazolam, midazolam + fentanyl and Level 2 propofol generate a higher risk of hypoventilation and desaturation. (A2) Yildizdas et al. 2004 [8 ] (2) Serious PS-related adverse events occur less frequently if specifically trained professionals working in dedicated Level 2 teams perform sedation according to international guidelines. (B) Barbi et al. 2003 [12 ], Hoffman et al. 2002 [13 ], Cravero et al. 2009 [26 ] (C) Vespasiano et al. 2007 [29 ]